INCOME TAXES	9 Months Ended
Dec. 31, 2013
INCOME TAXES [Abstract]
INCOME TAXES	NOTE 13. INCOME TAXES During the three months ended December 31, 2013 and 2012, our income tax provision was $1.6 million, based on an effective tax rate of 34%, and $3.0 million, based on an effective tax rate of 38%, respectively. During the nine months ended December 31, 2013 and 2012, our income tax provision was $5.7 million, based on an effective tax rate of 35%, and $12.7 million, based on an effective tax rate of 38%, respectively. The effective tax rates during the three months ended December 31, 2013, as compared to the three months ended December 31, 2012, decreased primarily due to reinstatement of federal research tax credits on January 2, 2013 and a reduction in state tax expense, partially offset by an increase in non-deductible share-based compensation expense. The effective tax rates during the nine months ended December 31, 2013, as compared to the nine months ended December 31, 2012, decreased primarily due to (a) reinstatement of federal research tax credits on January 2, 2013, (b) a reduction in state tax expense and (c) a discrete tax expense of approximately $6.7 million due to a gain from our legal settlement with Cepheid during the second quarter of fiscal 2013, partially offset by an increase in non-deductible share-based compensation expense. We did not have any unrecognized tax benefits as of December 31, 2013 and March 31, 2013. During the three and nine months ended December 31, 2013 and 2012, we did not recognize any interest or penalties related to unrecognized tax benefits. In September 2013, the U.S. Department of the Treasury issued final regulations on the deduction and capitalization of expenditures related to tangible property for income tax purposes. These regulations will apply to the Company’s fiscal year starting April 1, 2014. The Company is currently assessing the financial statement impact of these regulations.

INCOME TAXES

9 Months Ended

Dec. 31, 2013

NOTE 13. INCOME TAXES

During the three months ended December 31, 2013 and 2012, our income tax provision was $1.6 million, based on an effective tax rate of 34%, and $3.0 million, based on an effective tax rate of 38%, respectively. During the nine months ended December 31, 2013 and 2012, our income tax provision was $5.7 million, based on an effective tax rate of 35%, and $12.7 million, based on an effective tax rate of 38%, respectively. The effective tax rates during the three months ended December 31, 2013, as compared to the three months ended December 31, 2012, decreased primarily due to reinstatement of federal research tax credits on January 2, 2013 and a reduction in state tax expense, partially offset by an increase in non-deductible share-based compensation expense. The effective tax rates during the nine months ended December 31, 2013, as compared to the nine months ended December 31, 2012, decreased primarily due to (a) reinstatement of federal research tax credits on January 2, 2013, (b) a reduction in state tax expense and (c) a discrete tax expense of approximately $6.7 million due to a gain from our legal settlement with Cepheid during the second quarter of fiscal 2013, partially offset by an increase in non-deductible share-based compensation expense.

We did not have any unrecognized tax benefits as of December 31, 2013 and March 31, 2013. During the three and nine months ended December 31, 2013 and 2012, we did not recognize any interest or penalties related to unrecognized tax benefits.

In September 2013, the U.S. Department of the Treasury issued final regulations on the deduction and capitalization of expenditures related to tangible property for income tax purposes. These regulations will apply to the Company’s fiscal year starting April 1, 2014. The Company is currently assessing the financial statement impact of these regulations.